Akili Inc [AKLI] stock is trading at $0.45, up 104.11%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AKLI shares have gain 88.46% over the last week, with a monthly amount glided 77.30%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 26, February 2024, Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan. In a post published today on Yahoo Finance, Japanese Product Now Under Review for Nationwide Marketing Approval.
From an analyst’s perspective:
Akili Inc [NASDAQ: AKLI] stock has seen the most recent analyst activity on November 18, 2022, when BofA Securities initiated its Neutral rating and assigned the stock a price target of $2. Previously, Credit Suisse started tracking the stock with Outperform rating on October 25, 2022, and set its price target to $5. On September 06, 2022, Cowen initiated with a Outperform rating.
Akili Inc [AKLI] stock has fluctuated between $0.19 and $2.08 over the past year. Currently, Wall Street analysts expect the stock to reach $3.25 within the next 12 months. Akili Inc [NASDAQ: AKLI] shares were valued at $0.45 at the most recent close of the market. An investor can expect a potential return of 622.22% based on the average AKLI price forecast.
Analyzing the AKLI fundamentals
Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3468 points at the first support level, and at 0.2413 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6481, and for the 2nd resistance point, it is at 0.8439.
Akili Inc [AKLI] reported earnings per share of -$0.18 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.19/share, meaning a difference of $0.01 and a surprise factor of 5.30%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.16 per share as compared to estimates of -$0.2 per share, a difference of $0.04 representing a surprise of 20.00%.
Ratios To Look Out For
For context, Akili Inc’s Current Ratio is 6.95. Further, the Quick Ratio stands at 6.95, while the Cash Ratio is 0.05.
Transactions by insiders
Recent insider trading involved Martucci Walter Edward II, Chief Executive Officer, that happened on Sep 11 when 2353.0 shares were sold. President & COO, Franklin Matthew completed a deal on Sep 11 to sell 1728.0 shares. Meanwhile, Chief Legal Officer Studer Jacqueline sold 1130.0 shares on Sep 11.
